Reply by Authors

Avril Lusty¹, R Christopher Doiron¹, Christopher M Booth^{2

3}, Marlo Whitehead⁴, D Robert Siemens^{1

2

3}

Affiliations

¹ Department of Urology, Queen's University, Kingston, Ontario, Canada.
² Department of Oncology, Queen's University, Kingston, Ontario, Canada.
³ Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
⁴ ICES-Queen's, Health Services and Policy Research Institute, Queen's University, Kingston, Ontario, Canada.

Comment

Avril Lusty et al. J Urol. 2021 Aug.

. 2021 Aug;206(2):268-269.

doi: 10.1097/JU.0000000000001715.02. Epub 2021 May 13.

Avril Lusty¹, R Christopher Doiron¹, Christopher M Booth^{2

3}, Marlo Whitehead⁴, D Robert Siemens^{1

2

3}

¹ Department of Urology, Queen's University, Kingston, Ontario, Canada.
² Department of Oncology, Queen's University, Kingston, Ontario, Canada.
³ Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
⁴ ICES-Queen's, Health Services and Policy Research Institute, Queen's University, Kingston, Ontario, Canada.

No abstract available

Comment on

Editorial Comment.
Lonati C, Simeone C, Moschini M. Lonati C, et al. J Urol. 2021 Aug;206(2):268. doi: 10.1097/JU.0000000000001715.01. Epub 2021 May 13. J Urol. 2021. PMID: 33983823 No abstract available.